Skip to content

Clinical trials

Phase 2 Angioedemas, Hereditary trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Angioedemas, Hereditary Phase: Phase 2 Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20091
20102
20111
20121
20133
20141
20161
20171
20181
20191
20203
20212
20221
20231
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Active, not recruiting2
Terminated2
Recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shire5
BioCryst Pharmaceuticals3
Pharming Technologies B.V.3
Ionis Pharmaceuticals, Inc.2
Pharvaris Netherlands B.V.2
Astria Therapeutics, Inc.1
CSL Behring1
KalVista Pharmaceuticals, Ltd.1
Leiden University Medical Center1
NYU Langone Health1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Angioedemas, Hereditary23
Hereditary Angioedema Types I and II3
Angioedema2
Brain Injuries, Traumatic1
COVID-191
Coronavirus Infections1
Craniocerebral Trauma1
Cytokine Release Syndrome1
Genetic Diseases, Inborn1
Neuroinflammatory Diseases1

Trials

Showing 51 to 23 of 23. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.